MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players

Transcription

1 Brochure More information from MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players Description: MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players Summary GlobalData has released its medical device report, MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the steadily growing In-Vitro Colorectal Cancer Screening Tests Market. Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment. Scope - Investigation of current and future market competition for In-Vitro Colorectal Cancer Screening Tests. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as interventional cardiologists and radiologists already using In-Vitro Colorectal Cancer Screening Tests in clinical practice. Reasons to buy - Gain a high level view of the trends shaping and driving the In-Vitro Colorectal Cancer Screening Tests market for coronary applications and peripheral applications in the lower extremity. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Take a comprehensive look at the market s device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market Contents: List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 3 Competitive Assessment 3.1 Overview 3.2 Fecal Occult Blood Tests Guaiac Fecal Occult Blood Stool Tests Lateral Flow Immuno-Fecal Occult Blood Tests Readers Immuno-FOB Test ELISA Immuno-FOB Agglutination Tests

2 3.3 CRC DNA Screening Tests Panel DNA Tests Methylated Gene Testing 3.4 Other Biomarker Tests Overview Tumor M2-PK Stool Test/2-in-1 Quick Test Transferrin Assays 4 Pipeline Products 4.1 Overview 4.2 Pipeline by Phases in Development 4.3 Pipeline Product Profiles BST1 CRC Assay Cologic ColoGuard Colon Cancer BEC Test Colon MarCare Plex Colox CRC Bacterial Signature Assay CRC Breath Test Epi procolon ExiQon MicroRNA Test Gemini CRC Biomarker Assay GenomicTree Methylated DNA Test Measure Fecal Occult Blood Test Metabiomics CRC Test MiR-21 Test Oncolite CR PanC-Dx 5 Current and Future Players 5.1 Overview 5.2 Trends in Corporate Strategy 5.3 Company Profiles Abbott Molecular Alere Beckman Coulter Biomarcare Technologies Companion Dx Eiken Chemical Epigenomics Exact Sciences ExiQon Fujirebio (Miraca Holdings) GeneNews GenomicTree Immunostics Kyowa Medex MDx Health (was OncoMethylome) Merck Millipore Metabiomics Mode Diagnostics Oncocyte (Bio Time) Quest Diagnostics R-Biopharm Randox Laboratories ScheBo Biotech SciMarket Technologies Siemens Healthcare Signature Diagnostics Sysmex Veda Lab 6 Appendix 6.1 Abbreviations 6.2 Bibliography

3 6.3 Research Methodology Coverage Secondary Research 6.4 Physicians and Specialists Included in this Study 6.5 Primary Research 6.6 About the Authors Analysts Global Head of Healthcare 6.7 About Us 6.8 Disclaimer 1.1 List of Tables Table 1: CRC Screening Test Segmentation Table 2: Guaiac Fecal Occult Blood Tests Product Profile Table 3: Guaiac FOB Test SWOT Analysis, 2013 Table 4: Immuno-FOB Tests Table 5: Product Profile - Lateral Flow Immunochemical Fecal Occult Blood Tests Table 6: Lateral Flow Immunochemical Fecal Occult Blood Tests SWOT Analysis, 2013 Table 7: Product Profile - Veda Lab Easy Reader (Lateral Flow Immunochemical Fecal Occult Blood Tests with Readers) Table 8: Veda Lab Easy Reader (Lateral Flow Immunochemical Fecal Occult Blood Tests with Readers) SWOT Analysis, 2013 Table 9: Fecal Occult Blood ELISA Products Table 10: Product Profile - Fecal Occult Blood ELISA Table 11: Immuno-FOB Test ELISA SWOT Analysis, 2013 Table 12: Commercially Available Immuno-FOB Agglutination Test Systems Table 13: Product Profile - Immuno-FOB Agglutination Tests Table 14: Immuno-FOB Agglutination Tests SWOT Analysis, 2013 Table 15: Key Mutations Associated with CRC Table 16: Key Stages of PCR Gene Test Table 17: Product Profile - PreGen Plus Table 18: PreGen Plus SWOT Analysis, 2013 Table 19: Product Profile - K-RAS, B-RAF, PIK3CA Array Table 20: K-RAS, B-RAF, PIK3CA Array SWOT Analysis, 2013 Table 21: Product Profile - Colonsentry Table 22: Colonsentry SWOT Analysis, 2013 Table 23: Product Profile - Detector C 2.0 Table 24: Detector C SWOT Analysis, 2013 Table 25: Product Profile - ColoSure Table 26: ColoSure SWOT Analysis, 2013 Table 27: Product Profile - MS9 Table 28: MS9 SWOT Analysis, 2013 Table 29: Septin-9 CRC Screening Marketed Laboratory-Developed Tests Table 30: Product Profile - ColoVantage/Septin-9 Table 31: ColoVantage/Septin-9 SWOT Analysis, 2013 Table 32: Product Profile - Tumor M2-PK Stool Test/2-in-1 Quick Test Table 33: Tumor M2-PK Stool Test/2-in-1 Quick Test SWOT Analysis, 2013 Table 34: Product Profile - Transferrin Assays Table 35: Transferrin Assays SWOT Analysis, 2013 Table 36: CRC Screening Tests Pipeline, 2012 Table 37: Product Profile - BST1 CRC Assay Table 38: BST1 CRC Assay SWOT Analysis, 2013 Table 39: Product Profile - Cologic Table 40: Cologic SWOT Analysis, 2013 Table 41: Product Profile - ColoGuard Table 42: ColoGuard SWOT Analysis, 2013 Table 43: Product Profile - Colon Cancer BEC Test Table 44: Colon Cancer BEC Test SWOT Analysis, 2013 Table 45: Product Profile - Colon MarCare Plex Table 46: Colon MarCare Plex SWOT Analysis, 2013 Table 47: Product Profile - Colox Table 48: Colox SWOT Analysis, 2013 Table 49: Product Profile - CRC Bacterial Signature Assay

4 Table 50: CRC Bacterial Signature Assay SWOT Analysis, 2013 Table 51: Product Profile - CRC Breath Test Table 52: CRC Breath Test SWOT Analysis, 2013 Table 53: Product Profile - Epi procolon Table 54: Epi procolon Clinical Trials Table 55: Epi procolon SWOT Analysis, 2013 Table 56: ExiQon MicroRNA Sensitivity and Specificity Table 57: Product Profile - ExiQon microrna Test Table 58: ExiQon microrna Test SWOT Analysis, 2013 Table 59: Product Profile - Gemini CRC Biomarker Assay Table 60: Gemini CRC Biomarker Assay SWOT Analysis, 2013 Table 61: Product Profile - GenomicTree Methylated DNA Test Table 62: GenomicTree Methylated DNA Test SWOT Analysis, 2013 Table 63: Product Profile - Measure Table 64: Measure SWOT Analysis, 2013 Table 65: Product Profile - Metabiomics CRC Test Table 66: Metabiomics CRC Test SWOT Analysis, 2013 Table 67: Product Profile - mir-21 Test Table 68: mir-21 Test SWOT Analysis, 2013 Table 69: Product Profile - Oncolite-CR Table 70: Oncolite-CR SWOT Analysis, 2013 Table 71: Product Profile - PanC-Dx Table 72: PanC-Dx SWOT Analysis, 2013 Table 73: Company Profile - Abbott Molecular Table 74: Abbott Molecular SWOT Analysis, 2013 Table 75: Company Profile - Alere Table 76: Alere SWOT Analysis, 2013 Table 77: Company Profile - Beckman Coulter Table 78: Beckman Coulter SWOT Analysis, 2013 Table 79: Company Profile - Biomarcare Technologies Table 80: Biomarcare Technologies SWOT Analysis, 2013 Table 81: Company Profile - Companion Dx Table 82: Companion Dx SWOT Analysis, 2013 Table 83: Company Profile - Eiken Chemical Table 84: Eiken Chemical SWOT Analysis, 2013 Table 85: Company Profile - Epigenomics Table 86: Epigenomics SWOT Analysis, 2013 Table 87: Company Profile - Exact Sciences Table 88: Exact Sciences SWOT Analysis, 2013 Table 89: Company Profile - ExiQon Table 90: ExiQon SWOT Analysis, 2013 Table 91: Company Profile - Fujirebio (Miraca Holdings) Table 92: Fujirebio SWOT Analysis, 2013 Table 93: Company Profile - GeneNews Table 94: GeneNews SWOT Analysis, 2013 Table 95: Company Profile - GenomicTree Table 96: GenomicTree SWOT Analysis, 2013 Table 97: Company Profile - Immunostics Table 98: Immunostics SWOT Analysis, 2013 Table 99: Company Profile - Kyowa Medex (Kyowa Hakko Kirin Group) Table 100: Kyowa Medex SWOT Analysis, 2013 Table 101: Company Profile - MDx Health Table 102: MDx Health SWOT Analysis, 2013 Table 103: Company Profile - Merck Millipore Table 104: Merck Millipore SWOT Analysis, 2013 Table 105: Company Profile - Metabiomics Table 106: Metabiomics SWOT Analysis, 2013 Table 107: Company Profile - Mode Diagnostics Table 108: Mode Diagnostics SWOT Analysis, 2013 Table 109: Company Profile - Oncocyte (Bio Time) Table 110: Oncocyte (Bio Time) SWOT Analysis, 2013 Table 111: Company Profile - Quest Diagnostics Table 112: Quest Diagnostics SWOT Analysis, 2013

5 Table 113: Company Profile - R-Biopharm Table 114: R-Biopharm SWOT Analysis, 2013 Table 115: Company Profile - Randox Laboratories Table 116: Randox Laboratories SWOT Analysis, 2013 Table 117: Company Profile - ScheBo Biotech Table 118: Schebo Biotech SWOT Analysis, 2013 Table 119: Company Profile - SciMarket Technologies Table 120: SciMarket Technologies SWOT Analysis, 2013 Table 121: Company Profile - Siemens Healthcare Table 122: Siemens Healthcare SWOT Analysis, 2013 Table 123: Company Profile - Signature Diagnostics Table 124: Signature Diagnostics SWOT Analysis, 2013 Table 125: Company Profile - Sysmex Table 126: Sysmex SWOT Analysis, 2013 Table 127: Company Profile - Veda Lab Table 128: Veda Lab SWOT Analysis, List of Figures Figure 1: Example of a Guaiac Fecal Occult Blood Card: Immunostics Hema-Screen Figure 2: Fecal Occult Blood Test Lateral Flow Device Architecture Figure 3: Biohit Colonview (example of immuno-fob test) Figure 4: Beckman Coulter Hemoccult-ICT (example of immuno-fob test) Figure 5: Veda Labs Easy Reader Immuno-FOB Test LFD Reader Figure 6: OC-Hemodia Agglutination FOB Test (manually performed) Figure 7: OC-Sensor/Diana FOB Test Sample Cartridge Figure 8: OC-Sensor/Diana FOB Test Instrument Figure 9: Fujirebio HemSp/MagStream HT Magnetic Agglutination Reaction Figure 10: Sentinel Diagnostic Sentifob Instrument Figure 11: Alere CI5 NS-Plus Instrument Figure 12: Orion Diagnostics Quikread FOB Test and Instrument Figure 13: Basic PCR Process Figure 14: MS9 PCR Response Curve Figure 15: Proposed ColoGuard Patient Stool Sample Collection Kit Figure 16: Exact Sciences Automated Sample Processing WorkStation Figure 17: Colox Kit Contents Figure 18: Measure Fecal Occult Blood Test Figure 19: PanC-Dx Multiplex Detection of CRC-specific Biomarker Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

6 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Web Address: Office Code: MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players SC Product Formats Please select the product formats and quantity you require: Electronic (PDF) - Single User: Electronic (PDF) - Site License: Electronic (PDF) - Enterprisewide: Quantity USD 3500 USD 5385 USD 8300 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

7 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World